Arcadia Biosciences (RKDA) Gross Profit (2016 - 2025)
Arcadia Biosciences' Gross Profit history spans 12 years, with the latest figure at $192000.0 for Q4 2025.
- For Q4 2025, Gross Profit fell 50.64% year-over-year to $192000.0; the TTM value through Dec 2025 reached $1.8 million, down 15.55%, while the annual FY2025 figure was $1.8 million, 15.47% down from the prior year.
- Gross Profit reached $192000.0 in Q4 2025 per RKDA's latest filing, down from $418000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $835.4 million in Q2 2021 to a low of -$6.7 million in Q4 2022.
- Average Gross Profit over 5 years is $41.8 million, with a median of $492500.0 recorded in 2023.
- Peak YoY movement for Gross Profit: surged 69199.5% in 2021, then crashed 1329.3% in 2022.
- A 5-year view of Gross Profit shows it stood at $546000.0 in 2021, then plummeted by 1329.3% to -$6.7 million in 2022, then surged by 108.92% to $599000.0 in 2023, then tumbled by 35.06% to $389000.0 in 2024, then tumbled by 50.64% to $192000.0 in 2025.
- Per Business Quant, the three most recent readings for RKDA's Gross Profit are $192000.0 (Q4 2025), $418000.0 (Q3 2025), and $631000.0 (Q2 2025).